Vektor Medical has secured a $16 million Series A investment co-led by Solas BioVentures & TVM Capital Life Science.

SAN DIEGO, April 23, 2025--Vektor Medical, a leader in non-invasive, AI-powered arrhythmia analysis technology, today announced the initiation of the IMPRoVED AF clinical study designed to ...

Vektor Medical, a leader in non-invasive, AI-powered arrhythmia analysis technology, will showcase its transformative vMap technology at Heart Rhythm 2025, t ...

Despite his attempt to appeal to the metal community for a second chance for himself and Vektor, it looks like the issues are going to continue. It’s important to note that we have not heard directly ...